Evidence map›Paper›PMID 28509881›Full record

ReviewInternational journal of molecular sciences2017

dFmr1 Plays Roles in Small RNA Pathways of Drosophila melanogaster.

Valeria Specchia, Simona D'Attis, Antonietta Puricella, Maria Pia Bozzetti

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Genes · 2022
    Review
  4. TheCells · 2022
    Article
  5. Article
  6. Article
  7. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  8. Over-expression of Hsp83 in grossly depletedJournal of biosciences · 2019
    Article
  9. Article
  10. Frontiers in genetics · 2019
    Review
  11. Modeling Fragile X Syndrome inFrontiers in molecular neuroscience · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Valeria SpecchiaDipartimento di Scienze e Tecnologie Biologiche ed Ambientali (DiSTeBA)-University of Salento, 73100 Lecce, Italy. valeria.specchia@unisalento.it.
Simona D'AttisDipartimento di Scienze e Tecnologie Biologiche ed Ambientali (DiSTeBA)-University of Salento, 73100 Lecce, Italy. simonadattis@libero.it.
Antonietta PuricellaDipartimento di Scienze e Tecnologie Biologiche ed Ambientali (DiSTeBA)-University of Salento, 73100 Lecce, Italy. antonietta.puricella@gmail.com.
Maria Pia BozzettiDipartimento di Scienze e Tecnologie Biologiche ed Ambientali (DiSTeBA)-University of Salento, 73100 Lecce, Italy. maria.bozzetti@unisalento.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile-X syndrome is the most common form of inherited mental retardation accompanied by other phenotypes, including macroorchidism. The disorder originates with mutations in the

Indexed as

Gene Expression RegulationAnimalsCarrier ProteinsDrosophila melanogasterDrosophila ProteinsEpistasis, GeneticEvolution, MolecularFragile X Messenger Ribonucleoprotein 1GonadsHumansProtein BindingRNA InterferenceRNA, Small InterferingRNA, Small UntranslatedCarrier ProteinsDrosophila ProteinsFMR1 protein, DrosophilaFragile X Messenger Ribonucleoprotein 1RNA, Small InterferingRNA, Small Untranslatedcrystal-Stellate systemdFmr1 interactorsFMRP/dFmr1fragile-X syndromepiRNA pathway

Identifiers

PMID28509881
PMCPMC5454977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.